All articles tagged: Major depressive disorder, single episode, moderate (F32.1)

By age 75 years, approximately half the global population can expect to develop a mental disorder, according to a study published online July 30 in The Lancet Psychiatry.John J. McGrath, Ph.D., from Queensland Centre for Mental Health Research in Brisbane, Australia, and colleagues used data from 156,331 adult participants in the World M

A novel sequential bilateral neurostimulation protocol has the potential to improve treatment-resistant major depressive disorder (TR-MDD), according to a letter published in the November issue of Brain Stimulation.Sabrina K. Segal, Ph.D., from the Family Care Center in Lone Tree, Colorado, and colleagues conducted a naturalistic

Symptom burden during repetitive transcranial magnetic stimulation (rTMS) treatment for major depressive disorder (MDD) may be most accurately assessed through use of multiple instruments, according to a study published in the December issue of Psychiatry Research.Michael K. Leuchter, M.D., from the University of California, Los An

A study shows that psilocybin-assisted therapy can effectively reduce depressive symptoms, offering promise as a treatment for major depressive disorder.

For patients with cancer and major depressive disorder, psilocybin is effective for reducing depression severity and is acceptable from the patient perspective, according to two studies published online Dec. 18 in Cancer.Manish Agrawal, M.D., from Sunstone Therapies in Rockville, Maryland, and colleagues examined the safety, feasibilit

Tardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.Rakesh Jain, M.D., M.P.H., from the Texas Tech University School of Medicine-Permian Basin in Midland, and colleagues conducted an online survey to assess pati

For patients with major depressive disorder (MDD), pretreatment pupillary light reflex (PLR) could predict clinical improvement with repetitive transcranial magnetic stimulation (rTMS) treatment, and improvement in depression is better for those receiving intermittent theta burst stimulation (iTBS), according to one study published online Oct. 15 in the

Metabolomic profiling may improve the differential diagnosis of mood disorders, according to a proof-of-concept study published online Oct. 25 in JAMA Psychiatry.Jakub Tomasik, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined metabolomic biomarker signatures from dried blood spots among patients